Wishing you all the joys of the season! 
Asia Pacific Transdermal Drug Delivery System Market Forecast to 2030
Asia Pacific Transdermal Drug Delivery System Market Forecast to 2030 – Regional Analysis – by Type (Transdermal Patches, Transdermal Gel, Transdermal Sprays, and Others), Application (Cardiovascular Diseases, Central Nervous System Disorders, Pain Management, Hormonal Applications, and Other Applications), and Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
$2,485 – $3,885
- Description
- Toplines
- Reasons for Buying
- Table of Contents
- List of Tables
- LIst of Figures
- List of Companies
- Reviews (0)
Description
The Asia Pacific transdermal drug delivery system market is expected to grow from US$ 9,029.89 million in 2022 to US$ 12,820.77 million by 2030. It is estimated to register a CAGR of 4.5% from 2022 to 2030.
Advancements in Smart Patches and 3D-Printed Patches Fuel Asia Pacific Transdermal Drug Delivery System Market
A transdermal drug administration route is novel and one of the reliable means of sustained drug delivery. With significant research being conducted in this field and the increasing interest of researchers in this form of drug delivery, a large number of transdermal patches are likely to reach the marketplace in the future. Transdermal patches are used to deliver drugs such as nicotine, fentanyl, nitroglycerin, and clonidine to treat various medical conditions. Recently, these patches have been explored to deliver biologics in various applications. Smart patches are equipped with sensors and other technologies to monitor patient conditions and adjust drug delivery accordingly. In January 2023, a lead scientist at Swansea University developed a new smart patch to detect proinflammatory biomarkers of neurodegenerative diseases such as Parkinson’s and Alzheimer’s using the microneedle technology. These smart patches comprise numerous microneedles designed to penetrate the skin barrier in a minimally invasive manner, followed by monitoring the biomarkers of clinical significance. They can be self-administered for point-of-care diagnosis at general practices or at home. This innovative research can potentially change the landscape of early neurodegenerative disease detection.
According to an article titled “3D-Printed Products for Topical Skin Applications: From Personalized Dressings to Drug Delivery,” published in the National Library of Medicine in November 2021, personalized 3D-printed patches that conform to the skin surface can be used for acetyl-hexapeptide 3 (AHP-3) delivery. In this study, two liquid monomers-polyethylene glycol diacrylate (PEGDA) and vinylpyrrolidone (VP)-were used in different proportions to improve the mechanical strength, polymerization rate, and swelling rate of the final polymer. Optimal drug loading on the resin indicated that AHP-3 remained stable throughout the manufacturing process and had no effect on the physical properties of the final polymer. Using a 3D scanned facial model, a personalized patch was designed in computer-aided design software, and it was fabricated in optimized resin using a digital light processing 3D printer. The in-vitro characterization of prepared transdermal patches has shown their ability to penetrate human cadaver skin, further remaining intact upon compression. “3D-Printed Products for Topical Skin Applications: From Personalized Dressings to Drug Delivery” is the first study demonstrating personalized patches made using photopolymers, and it has introduced a novel approach to improve the transdermal delivery of drugs for effective wrinkle management.
Thus, the adoption of 3D printing technology and smart patches is likely to offer opportunities to the transdermal drug delivery systems market in the coming years.
Asia Pacific Transdermal Drug Delivery System Market Overview
The Asia Pacific transdermal drug delivery systems market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. The market growth is expected to be fastest in countries such as China, India, and Australia due to growing aging population, increasing prevalence of cardiovascular diseases, and increasing demand for non-invasive medical devices. In Asia Pacific, China is the largest market of transdermal drug delivery systems. The growth of the transdermal drug delivery system market in China is primarily attributed to the growing technology in the country, increasing developments by the market players to develop transdermal patches and semisolid products for pain management.
Also, in the last few years, companies in China are undergoing product launches and approvals, acquisitions, partnerships, and mergers to expand their business in the transdermal drug delivery systems industry. For instance, in January 2022, Suzhou Reveda Medical Co., Ltd. (REVEDA) announced that it partnered with Hybio Pharmaceutical Co., Ltd. (Hybio Pharmaceutical) to set up a joint venture for drug-device combination products and team up in the field of polypeptide micro-needles for transdermal delivery. 60% of the joint venture will be owned by REVEDA Medical and 40% by Hybio Pharmaceutical. Furthermore, in September 2021, the UK’s Medicines and Healthcare Products Regulatory Agency granted marketing approval for Luye Pharma Group’s innovative formulation Rivastigmine Multi-Day Transdermal Patch (Rivastigmine MD) for the treatment of mild to moderate dementia associated with Alzheimer’s disease. Several European Union nations already have marketing authorization for the medicine. Thus, owing to the abovementioned factors, the market is expected to propel the demand for transdermal drug delivery systems in this country in the upcoming years.
Asia Pacific Transdermal Drug Delivery System Market Revenue and Forecast to 2030 (US$ Million)
Asia Pacific Transdermal Drug Delivery System Market Segmentation
The Asia Pacific transdermal drug delivery system market is segmented into type, application, distribution channel, and country.
Based on type, the Asia Pacific transdermal drug delivery system market is segmented into transdermal patches, transdermal gel, transdermal sprays, and others. The transdermal gel segment held the largest share of the Asia Pacific transdermal drug delivery system market in 2022. The transdermal patches is further sub segmented into drug-in-adhesive patches, matrix patches, reservoir membrane patches, and vapor patches.
In terms of application, the Asia Pacific transdermal drug delivery system market is categorized into cardiovascular diseases, central nervous system disorders, pain management, hormonal applications, and other applications. The pain management segment held the largest share of the Asia Pacific transdermal drug delivery system market in 2022. The pain management is further sub segmented into opioid and non-opioid. The hormonal applications is further sub segmented into transdermal estrogen & progesterone therapy and testosterone replacement.
By distribution channel, the Asia Pacific transdermal drug delivery system market is segmented into hospitals pharmacies, retail pharmacies, online pharmacies, and others. The hospitals pharmacies segment held the largest share of the Asia Pacific transdermal drug delivery system market in 2022.
Based on country, the Asia Pacific transdermal drug delivery system market is categorized into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific transdermal drug delivery system market in 2022.
Boehringer Ingelheim International GmbH, GSK Plc, Hisamitsu Pharmaceutical Co Inc, Johnson & Johnson, Luye Pharma Group Ltd, Novartis AG, and Viatris Inc are some of the leading companies operating in the Asia Pacific transdermal drug delivery system market.
Advancements in Smart Patches and 3D-Printed Patches Fuel Asia Pacific Transdermal Drug Delivery System Market
A transdermal drug administration route is novel and one of the reliable means of sustained drug delivery. With significant research being conducted in this field and the increasing interest of researchers in this form of drug delivery, a large number of transdermal patches are likely to reach the marketplace in the future. Transdermal patches are used to deliver drugs such as nicotine, fentanyl, nitroglycerin, and clonidine to treat various medical conditions. Recently, these patches have been explored to deliver biologics in various applications. Smart patches are equipped with sensors and other technologies to monitor patient conditions and adjust drug delivery accordingly. In January 2023, a lead scientist at Swansea University developed a new smart patch to detect proinflammatory biomarkers of neurodegenerative diseases such as Parkinson’s and Alzheimer’s using the microneedle technology. These smart patches comprise numerous microneedles designed to penetrate the skin barrier in a minimally invasive manner, followed by monitoring the biomarkers of clinical significance. They can be self-administered for point-of-care diagnosis at general practices or at home. This innovative research can potentially change the landscape of early neurodegenerative disease detection.
According to an article titled “3D-Printed Products for Topical Skin Applications: From Personalized Dressings to Drug Delivery,” published in the National Library of Medicine in November 2021, personalized 3D-printed patches that conform to the skin surface can be used for acetyl-hexapeptide 3 (AHP-3) delivery. In this study, two liquid monomers-polyethylene glycol diacrylate (PEGDA) and vinylpyrrolidone (VP)-were used in different proportions to improve the mechanical strength, polymerization rate, and swelling rate of the final polymer. Optimal drug loading on the resin indicated that AHP-3 remained stable throughout the manufacturing process and had no effect on the physical properties of the final polymer. Using a 3D scanned facial model, a personalized patch was designed in computer-aided design software, and it was fabricated in optimized resin using a digital light processing 3D printer. The in-vitro characterization of prepared transdermal patches has shown their ability to penetrate human cadaver skin, further remaining intact upon compression. “3D-Printed Products for Topical Skin Applications: From Personalized Dressings to Drug Delivery” is the first study demonstrating personalized patches made using photopolymers, and it has introduced a novel approach to improve the transdermal delivery of drugs for effective wrinkle management.
Thus, the adoption of 3D printing technology and smart patches is likely to offer opportunities to the transdermal drug delivery systems market in the coming years.
Asia Pacific Transdermal Drug Delivery System Market Overview
The Asia Pacific transdermal drug delivery systems market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. The market growth is expected to be fastest in countries such as China, India, and Australia due to growing aging population, increasing prevalence of cardiovascular diseases, and increasing demand for non-invasive medical devices. In Asia Pacific, China is the largest market of transdermal drug delivery systems. The growth of the transdermal drug delivery system market in China is primarily attributed to the growing technology in the country, increasing developments by the market players to develop transdermal patches and semisolid products for pain management.
Also, in the last few years, companies in China are undergoing product launches and approvals, acquisitions, partnerships, and mergers to expand their business in the transdermal drug delivery systems industry. For instance, in January 2022, Suzhou Reveda Medical Co., Ltd. (REVEDA) announced that it partnered with Hybio Pharmaceutical Co., Ltd. (Hybio Pharmaceutical) to set up a joint venture for drug-device combination products and team up in the field of polypeptide micro-needles for transdermal delivery. 60% of the joint venture will be owned by REVEDA Medical and 40% by Hybio Pharmaceutical. Furthermore, in September 2021, the UK’s Medicines and Healthcare Products Regulatory Agency granted marketing approval for Luye Pharma Group’s innovative formulation Rivastigmine Multi-Day Transdermal Patch (Rivastigmine MD) for the treatment of mild to moderate dementia associated with Alzheimer’s disease. Several European Union nations already have marketing authorization for the medicine. Thus, owing to the abovementioned factors, the market is expected to propel the demand for transdermal drug delivery systems in this country in the upcoming years.
Asia Pacific Transdermal Drug Delivery System Market Revenue and Forecast to 2030 (US$ Million)
Asia Pacific Transdermal Drug Delivery System Market Segmentation
The Asia Pacific transdermal drug delivery system market is segmented into type, application, distribution channel, and country.
Based on type, the Asia Pacific transdermal drug delivery system market is segmented into transdermal patches, transdermal gel, transdermal sprays, and others. The transdermal gel segment held the largest share of the Asia Pacific transdermal drug delivery system market in 2022. The transdermal patches is further sub segmented into drug-in-adhesive patches, matrix patches, reservoir membrane patches, and vapor patches.
In terms of application, the Asia Pacific transdermal drug delivery system market is categorized into cardiovascular diseases, central nervous system disorders, pain management, hormonal applications, and other applications. The pain management segment held the largest share of the Asia Pacific transdermal drug delivery system market in 2022. The pain management is further sub segmented into opioid and non-opioid. The hormonal applications is further sub segmented into transdermal estrogen & progesterone therapy and testosterone replacement.
By distribution channel, the Asia Pacific transdermal drug delivery system market is segmented into hospitals pharmacies, retail pharmacies, online pharmacies, and others. The hospitals pharmacies segment held the largest share of the Asia Pacific transdermal drug delivery system market in 2022.
Based on country, the Asia Pacific transdermal drug delivery system market is categorized into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific transdermal drug delivery system market in 2022.
Boehringer Ingelheim International GmbH, GSK Plc, Hisamitsu Pharmaceutical Co Inc, Johnson & Johnson, Luye Pharma Group Ltd, Novartis AG, and Viatris Inc are some of the leading companies operating in the Asia Pacific transdermal drug delivery system market.
Summary Info
| Industry: | |
|---|---|
| Pricing options: | |
| Geographical coverage: | |
| Year of Publication: |
At 4.5% CAGR, Asia Pacific Transdermal Drug Delivery System Market is Speculated to be Worth US$ 12,820.77 million by 2030, says the Research Team
According to the Research Team research, the Asia Pacific transdermal drug delivery system market was valued at US$ 9,029.89 million in 2022 and is expected to reach US$ 12,820.77 million by 2030, registering a CAGR of 4.5% from 2022 to 2030. Increasing prevalence of chronic diseases and growing demand for noninvasive drug delivery devices are among the critical factors attributed to the Asia Pacific transdermal drug delivery system market expansion.
Traditional drug delivery techniques such as intramuscular, intravenous, and rectal drug administration are not preferred by certain patient populations mainly due to the pain and complexities associated with them. With the improvements in medical science and definite drug delivery technologies, noninvasive drug delivery systems are now set to compete with the traditional method of injectable route of drug administration. The noninvasive drug delivery systems include drug delivery via oral; topical; transdermal-active (device-aided enhanced penetration) and transdermal-passive; and transocular membrane, transmucosal membrane, and alveolar membrane from inhaled medication. Transdermal drug delivery is advantageous in many ways over the oral route of administration. In particular, it evades the first-pass mechanism of the liver, which can otherwise impulsively metabolize drugs.
Further, transdermal delivery is not as painful as hypodermic injections, and this route leads to no dangerous medical waste and poses no risk of disease transmission by needle reuse, which is especially common in developing and under-developed countries. In addition, a noninvasive transdermal drug delivery system has simplified dosing schedules, and the drugs can be self-administered. Patient compliance is much higher when drugs are administrated noninvasively due to low or no pain involved. Therefore, this route is considered a preferred mode of drug delivery. Moreover, a non-invasive drug delivery system can significantly reduce the cost of clinical use because of the self-administration of the drugs by the patients. Thus, the advantages associated with a noninvasive drug delivery facilitated by transdermal drug delivery systems drive the market growth.
On the contrary, adverse effects and recall of transdermal drug delivery systems hamper the Asia growth of Pacific transdermal drug delivery system market.
Based on type, the Asia Pacific transdermal drug delivery system market is segmented into transdermal patches, transdermal gel, transdermal sprays, and others. The transdermal gel segment held 39.9% share of Asia Pacific transdermal drug delivery system market in 2022, amassing US$ 3,602.70 million. It is projected to garner US$ 5,216.66 million by 2030 to expand at 4.7% CAGR during 2022-2030. The transdermal patches is further sub segmented into drug-in-adhesive patches, matrix patches, reservoir membrane patches, and vapor patches.
In terms of application, the Asia Pacific transdermal drug delivery system market is categorized into cardiovascular diseases, central nervous system disorders, pain management, hormonal applications, and other applications. The pain management segment held 40.8% share of Asia Pacific transdermal drug delivery system market in 2022, amassing US$ 3,683.57 million. It is projected to garner US$ 5,226.18 million by 2030 to expand at 4.5% CAGR during 2022-2030. The pain management is further sub segmented into opioid and non-opioid. The hormonal applications is further sub segmented into transdermal estrogen & progesterone therapy and testosterone replacement.
By distribution channel, the Asia Pacific transdermal drug delivery system market is segmented into hospitals pharmacies, retail pharmacies, online pharmacies, and others. The hospitals pharmacies segment held 43.1% share of Asia Pacific transdermal drug delivery system market in 2022, amassing US$ 3,892.91 million. It is projected to garner US$ 5,522.33 million by 2030 to expand at 4.5% CAGR during 2022-2030.
Based on country, the Asia Pacific transdermal drug delivery system market has been categorized into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. Our regional analysis states that China captured 31.6% share of Asia Pacific transdermal drug delivery system market in 2022. It was assessed at US$ 2,850.18 million in 2022 and is likely to hit US$ 4,156.97 million by 2030, exhibiting a CAGR of 4.8% during 2022-2030.
Key players operating in the Asia Pacific transdermal drug delivery system market are Boehringer Ingelheim International GmbH, GSK Plc, Hisamitsu Pharmaceutical Co Inc, Johnson & Johnson, Luye Pharma Group Ltd, Novartis AG, and Viatris Inc, among others.
In October 2023, Novartis completed the Spin-off of Sandoz, its Generics and Biosimilars business. Novartis executed separation of the Sandoz business to create an independent company by way of a 100% Spin-off.
In December 2022, Luye Pharma Group held an offline product has launched conference in Shanghai, together with an online event, to announce the launch of Ruoxinlin® (Toludesvenlafaxine Hydrochloride Extended-Release Tablets) in China. Ruoxinlin is China’s first class 1 innovative chemical drug independently developed locally for the treatment of Major Depressive Disorder (MDD) and protected by intellectual property rights. The drug provides a powerful new option for patients, bringing the treatment of MDD to a new level.
o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific Transdermal Drug Delivery System Market.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific Transdermal Drug Delivery System Market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific Transdermal Drug Delivery System Market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution
TABLE OF CONTENTS
1. Introduction
1.1 the Research Team Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Transdermal Drug Delivery System Market – Key Industry Dynamics
4.1 Market Drivers
4.1.1 Increasing Prevalence of Chronic Diseases
4.1.2 Growing Demand for Noninvasive Drug Delivery Devices
4.1.3 High Demand for Self-Administration of Drugs
4.2 Market Restraints
4.2.1 Adverse Effects and Recall of Transdermal Drug Delivery Systems
4.3 Market Opportunities
4.3.1 Advancements in Smart Patches and 3D-Printed Patches
4.4 Future Trends
4.4.1 Strategic Initiatives by Manufacturers
4.5 Impact Analysis
5. Transdermal Drug Delivery System Market – Asia Pacific Market Analysis
5.1 Asia Pacific Transdermal Drug Delivery System Market Revenue (US$ Mn), 2022 – 2030
6. Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 – by Type
6.1 Overview
6.2 Asia Pacific Transdermal Drug Delivery System Market Revenue Share, by Type 2022 & 2030 (%)
6.3 Transdermal Patches
6.3.1 Overview
6.3.2 Transdermal Patches: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
6.3.2.1 Drug-in-Adhesive Patches
6.3.2.1.1 Overview
6.3.2.1.2 Drug-in-Adhesive Patches: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
6.3.2.2 Matrix Patches
6.3.2.2.1 Overview
6.3.2.2.2 Matrix Patches: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
6.3.2.3 Reservoir Membrane Patches
6.3.2.3.1 Overview
6.3.2.3.2 Reservoir Membrane Patches: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
6.3.2.4 Vapor Patches
6.3.2.4.1 Overview
6.3.2.4.2 Vapor Patches: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
6.4 Transdermal Gels
6.4.1 Overview
6.4.2 Transdermal Gels: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
6.5 Transdermal Sprays
6.5.1 Overview
6.5.2 Transdermal Sprays: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
6.6 Others
6.6.1 Overview
6.6.2 Others: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
7. Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 – by Application
7.1 Overview
7.2 Asia Pacific Transdermal Drug Delivery System Market Revenue Share, by Application 2022 & 2030 (%)
7.3 Cardiovascular Diseases
7.3.1 Overview
7.3.2 Cardiovascular Diseases: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Central Nervous System Disorders
7.4.1 Overview
7.4.2 Central Nervous System Disorders: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Pain Management
7.5.1 Overview
7.5.2 Pain Management: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
7.5.2.1 Opioid
7.5.2.1.1 Overview
7.5.2.1.2 Opioid: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
7.5.2.2 Non-Opioid
7.5.2.2.1 Overview
7.5.2.2.2 Non-Opioid: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
7.6 Hormonal Applications
7.6.1 Overview
7.6.2 Hormonal Applications: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
7.6.2.1 Transdermal Estrogen & Progesterone Therapy
7.6.2.1.1 Overview
7.6.2.1.2 Transdermal Estrogen & Progesterone Therapy: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
7.6.2.2 Testosterone Replacement
7.6.2.2.1 Overview
7.6.2.2.2 Testosterone Replacement: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
7.7 Other Application
7.7.1 Overview
7.7.2 Other Application: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
8. Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 – by Distribution Channel
8.1 Overview
8.2 Asia Pacific Transdermal Drug Delivery System Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
8.3 Hospital Pharmacies
8.3.1 Overview
8.3.2 Hospital Pharmacies: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Retail Pharmacies
8.4.1 Overview
8.4.2 Retail Pharmacies: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Online Pharmacies
8.5.1 Overview
8.5.2 Online Pharmacies: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
9. Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 – Country Analysis
9.1 Asia Pacific Transdermal Drug Delivery System Market
9.1.1 Asia Pacific Transdermal Drug Delivery System Market, by Country, 2022 & 2030 (%)
9.1.1.1 China: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
9.1.1.1.1 Overview
9.1.1.1.2 China: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
9.1.1.1.3 China: Asia Pacific Transdermal Drug Delivery System Market, by Type, 2020-2030 (US$ Million)
9.1.1.1.3.1 China: Asia Pacific Transdermal Drug Delivery System Market, For Transdermal Patches by Type, 2020-2030 (US$ Million)
9.1.1.1.4 China: Asia Pacific Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
9.1.1.1.4.1 China: Asia Pacific Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
9.1.1.1.4.2 China: Asia Pacific Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
9.1.1.1.5 China: Asia Pacific Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
9.1.1.2 Japan: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
9.1.1.2.1 Overview
9.1.1.2.2 Japan: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
9.1.1.2.3 Japan: Asia Pacific Transdermal Drug Delivery System Market, by Type, 2020-2030 (US$ Million)
9.1.1.2.3.1 Japan: Asia Pacific Transdermal Drug Delivery System Market, For Transdermal Patches by Type, 2020-2030 (US$ Million)
9.1.1.2.4 Japan: Asia Pacific Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
9.1.1.2.4.1 Japan: Asia Pacific Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
9.1.1.2.4.2 Japan: Asia Pacific Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
9.1.1.2.5 Japan: Asia Pacific Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
9.1.1.3 India: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
9.1.1.3.1 Overview
9.1.1.3.2 India: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
9.1.1.3.3 India: Asia Pacific Transdermal Drug Delivery System Market, by Type, 2020-2030 (US$ Million)
9.1.1.3.3.1 India: Asia Pacific Transdermal Drug Delivery System Market, For Transdermal Patches by Type, 2020-2030 (US$ Million)
9.1.1.3.4 India: Asia Pacific Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
9.1.1.3.4.1 India: Asia Pacific Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
9.1.1.3.4.2 India: Asia Pacific Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
9.1.1.3.5 India: Asia Pacific Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
9.1.1.4 Australia: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
9.1.1.4.1 Overview
9.1.1.4.2 Australia: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
9.1.1.4.3 Australia: Asia Pacific Transdermal Drug Delivery System Market, by Type, 2020-2030 (US$ Million)
9.1.1.4.3.1 Australia: Asia Pacific Transdermal Drug Delivery System Market, For Transdermal Patches by Type, 2020-2030 (US$ Million)
9.1.1.4.4 Australia: Asia Pacific Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
9.1.1.4.4.1 Australia: Asia Pacific Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
9.1.1.4.4.2 Australia: Asia Pacific Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
9.1.1.4.5 Australia: Asia Pacific Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
9.1.1.5 South Korea: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
9.1.1.5.1 Overview
9.1.1.5.2 South Korea: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
9.1.1.5.3 South Korea: Asia Pacific Transdermal Drug Delivery System Market, by Type, 2020-2030 (US$ Million)
9.1.1.5.3.1 South Korea: Asia Pacific Transdermal Drug Delivery System Market, For Transdermal Patches by Type, 2020-2030 (US$ Million)
9.1.1.5.4 South Korea: Asia Pacific Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
9.1.1.5.4.1 South Korea: Asia Pacific Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
9.1.1.5.4.2 South Korea: Asia Pacific Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
9.1.1.5.5 South Korea: Asia Pacific Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
9.1.1.6 Rest of Asia Pacific: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
9.1.1.6.1 Overview
9.1.1.6.2 Rest of Asia Pacific: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
9.1.1.6.3 Rest of Asia Pacific: Asia Pacific Transdermal Drug Delivery System Market, by Type, 2020-2030 (US$ Million)
9.1.1.6.3.1 Rest of Asia Pacific: Asia Pacific Transdermal Drug Delivery System Market, For Transdermal Patches by Type, 2020-2030 (US$ Million)
9.1.1.6.4 Rest of Asia Pacific: Asia Pacific Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
9.1.1.6.4.1 Rest of Asia Pacific: Asia Pacific Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
9.1.1.6.4.2 Rest of Asia Pacific: Asia Pacific Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
9.1.1.6.5 Rest of Asia Pacific: Asia Pacific Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
10. Transdermal Drug Delivery System Market Industry Landscape
10.1 Overview
10.2 Growth Strategies in the Transdermal Drug Delivery System Market
10.3 Inorganic Growth Strategies
10.3.1 Overview
10.4 Organic Growth Strategies
10.4.1 Overview
11. Company Profiles
11.1 Novartis AG
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Johnson & Johnson
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 GSK Plc
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Viatris Inc
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Boehringer Ingelheim International GmbH
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Hisamitsu Pharmaceutical Co Inc
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Luye Pharma Group Ltd
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
12. Appendix
12.1 About Us
12.2 Glossary of Terms
1.1 the Research Team Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Transdermal Drug Delivery System Market – Key Industry Dynamics
4.1 Market Drivers
4.1.1 Increasing Prevalence of Chronic Diseases
4.1.2 Growing Demand for Noninvasive Drug Delivery Devices
4.1.3 High Demand for Self-Administration of Drugs
4.2 Market Restraints
4.2.1 Adverse Effects and Recall of Transdermal Drug Delivery Systems
4.3 Market Opportunities
4.3.1 Advancements in Smart Patches and 3D-Printed Patches
4.4 Future Trends
4.4.1 Strategic Initiatives by Manufacturers
4.5 Impact Analysis
5. Transdermal Drug Delivery System Market – Asia Pacific Market Analysis
5.1 Asia Pacific Transdermal Drug Delivery System Market Revenue (US$ Mn), 2022 – 2030
6. Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 – by Type
6.1 Overview
6.2 Asia Pacific Transdermal Drug Delivery System Market Revenue Share, by Type 2022 & 2030 (%)
6.3 Transdermal Patches
6.3.1 Overview
6.3.2 Transdermal Patches: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
6.3.2.1 Drug-in-Adhesive Patches
6.3.2.1.1 Overview
6.3.2.1.2 Drug-in-Adhesive Patches: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
6.3.2.2 Matrix Patches
6.3.2.2.1 Overview
6.3.2.2.2 Matrix Patches: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
6.3.2.3 Reservoir Membrane Patches
6.3.2.3.1 Overview
6.3.2.3.2 Reservoir Membrane Patches: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
6.3.2.4 Vapor Patches
6.3.2.4.1 Overview
6.3.2.4.2 Vapor Patches: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
6.4 Transdermal Gels
6.4.1 Overview
6.4.2 Transdermal Gels: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
6.5 Transdermal Sprays
6.5.1 Overview
6.5.2 Transdermal Sprays: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
6.6 Others
6.6.1 Overview
6.6.2 Others: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
7. Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 – by Application
7.1 Overview
7.2 Asia Pacific Transdermal Drug Delivery System Market Revenue Share, by Application 2022 & 2030 (%)
7.3 Cardiovascular Diseases
7.3.1 Overview
7.3.2 Cardiovascular Diseases: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Central Nervous System Disorders
7.4.1 Overview
7.4.2 Central Nervous System Disorders: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Pain Management
7.5.1 Overview
7.5.2 Pain Management: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
7.5.2.1 Opioid
7.5.2.1.1 Overview
7.5.2.1.2 Opioid: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
7.5.2.2 Non-Opioid
7.5.2.2.1 Overview
7.5.2.2.2 Non-Opioid: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
7.6 Hormonal Applications
7.6.1 Overview
7.6.2 Hormonal Applications: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
7.6.2.1 Transdermal Estrogen & Progesterone Therapy
7.6.2.1.1 Overview
7.6.2.1.2 Transdermal Estrogen & Progesterone Therapy: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
7.6.2.2 Testosterone Replacement
7.6.2.2.1 Overview
7.6.2.2.2 Testosterone Replacement: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
7.7 Other Application
7.7.1 Overview
7.7.2 Other Application: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
8. Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 – by Distribution Channel
8.1 Overview
8.2 Asia Pacific Transdermal Drug Delivery System Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
8.3 Hospital Pharmacies
8.3.1 Overview
8.3.2 Hospital Pharmacies: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Retail Pharmacies
8.4.1 Overview
8.4.2 Retail Pharmacies: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Online Pharmacies
8.5.1 Overview
8.5.2 Online Pharmacies: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
9. Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 – Country Analysis
9.1 Asia Pacific Transdermal Drug Delivery System Market
9.1.1 Asia Pacific Transdermal Drug Delivery System Market, by Country, 2022 & 2030 (%)
9.1.1.1 China: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
9.1.1.1.1 Overview
9.1.1.1.2 China: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
9.1.1.1.3 China: Asia Pacific Transdermal Drug Delivery System Market, by Type, 2020-2030 (US$ Million)
9.1.1.1.3.1 China: Asia Pacific Transdermal Drug Delivery System Market, For Transdermal Patches by Type, 2020-2030 (US$ Million)
9.1.1.1.4 China: Asia Pacific Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
9.1.1.1.4.1 China: Asia Pacific Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
9.1.1.1.4.2 China: Asia Pacific Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
9.1.1.1.5 China: Asia Pacific Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
9.1.1.2 Japan: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
9.1.1.2.1 Overview
9.1.1.2.2 Japan: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
9.1.1.2.3 Japan: Asia Pacific Transdermal Drug Delivery System Market, by Type, 2020-2030 (US$ Million)
9.1.1.2.3.1 Japan: Asia Pacific Transdermal Drug Delivery System Market, For Transdermal Patches by Type, 2020-2030 (US$ Million)
9.1.1.2.4 Japan: Asia Pacific Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
9.1.1.2.4.1 Japan: Asia Pacific Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
9.1.1.2.4.2 Japan: Asia Pacific Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
9.1.1.2.5 Japan: Asia Pacific Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
9.1.1.3 India: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
9.1.1.3.1 Overview
9.1.1.3.2 India: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
9.1.1.3.3 India: Asia Pacific Transdermal Drug Delivery System Market, by Type, 2020-2030 (US$ Million)
9.1.1.3.3.1 India: Asia Pacific Transdermal Drug Delivery System Market, For Transdermal Patches by Type, 2020-2030 (US$ Million)
9.1.1.3.4 India: Asia Pacific Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
9.1.1.3.4.1 India: Asia Pacific Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
9.1.1.3.4.2 India: Asia Pacific Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
9.1.1.3.5 India: Asia Pacific Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
9.1.1.4 Australia: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
9.1.1.4.1 Overview
9.1.1.4.2 Australia: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
9.1.1.4.3 Australia: Asia Pacific Transdermal Drug Delivery System Market, by Type, 2020-2030 (US$ Million)
9.1.1.4.3.1 Australia: Asia Pacific Transdermal Drug Delivery System Market, For Transdermal Patches by Type, 2020-2030 (US$ Million)
9.1.1.4.4 Australia: Asia Pacific Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
9.1.1.4.4.1 Australia: Asia Pacific Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
9.1.1.4.4.2 Australia: Asia Pacific Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
9.1.1.4.5 Australia: Asia Pacific Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
9.1.1.5 South Korea: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
9.1.1.5.1 Overview
9.1.1.5.2 South Korea: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
9.1.1.5.3 South Korea: Asia Pacific Transdermal Drug Delivery System Market, by Type, 2020-2030 (US$ Million)
9.1.1.5.3.1 South Korea: Asia Pacific Transdermal Drug Delivery System Market, For Transdermal Patches by Type, 2020-2030 (US$ Million)
9.1.1.5.4 South Korea: Asia Pacific Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
9.1.1.5.4.1 South Korea: Asia Pacific Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
9.1.1.5.4.2 South Korea: Asia Pacific Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
9.1.1.5.5 South Korea: Asia Pacific Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
9.1.1.6 Rest of Asia Pacific: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
9.1.1.6.1 Overview
9.1.1.6.2 Rest of Asia Pacific: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
9.1.1.6.3 Rest of Asia Pacific: Asia Pacific Transdermal Drug Delivery System Market, by Type, 2020-2030 (US$ Million)
9.1.1.6.3.1 Rest of Asia Pacific: Asia Pacific Transdermal Drug Delivery System Market, For Transdermal Patches by Type, 2020-2030 (US$ Million)
9.1.1.6.4 Rest of Asia Pacific: Asia Pacific Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
9.1.1.6.4.1 Rest of Asia Pacific: Asia Pacific Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
9.1.1.6.4.2 Rest of Asia Pacific: Asia Pacific Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
9.1.1.6.5 Rest of Asia Pacific: Asia Pacific Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
10. Transdermal Drug Delivery System Market Industry Landscape
10.1 Overview
10.2 Growth Strategies in the Transdermal Drug Delivery System Market
10.3 Inorganic Growth Strategies
10.3.1 Overview
10.4 Organic Growth Strategies
10.4.1 Overview
11. Company Profiles
11.1 Novartis AG
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Johnson & Johnson
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 GSK Plc
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Viatris Inc
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Boehringer Ingelheim International GmbH
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Hisamitsu Pharmaceutical Co Inc
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Luye Pharma Group Ltd
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
12. Appendix
12.1 About Us
12.2 Glossary of Terms
LIST OF TABLES
Table 1. Asia Pacific Transdermal Drug Delivery System Market Segmentation
Table 2. China: Asia Pacific Transdermal Drug Delivery System Market, by Type – Revenue and Forecast to 2030 (US$ Million)
Table 3. China: Asia Pacific Transdermal Drug Delivery System Market, For Transdermal Patches by Type – Revenue and Forecast to 2030 (US$ Million)
Table 4. China: Asia Pacific Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 5. China: Asia Pacific Transdermal Drug Delivery System Market, For Pain Management by Application – Revenue and Forecast to 2030 (US$ Million)
Table 6. China: Asia Pacific Transdermal Drug Delivery System Market, For Hormonal Applications by Application – Revenue and Forecast to 2030 (US$ Million)
Table 7. China: Asia Pacific Transdermal Drug Delivery System Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 8. Japan: Asia Pacific Transdermal Drug Delivery System Market, by Type – Revenue and Forecast to 2030 (US$ Million)
Table 9. Japan: Asia Pacific Transdermal Drug Delivery System Market, For Transdermal Patches by Type – Revenue and Forecast to 2030 (US$ Million)
Table 10. Japan: Asia Pacific Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 11. Japan: Asia Pacific Transdermal Drug Delivery System Market, For Pain Management by Application – Revenue and Forecast to 2030 (US$ Million)
Table 12. Japan: Asia Pacific Transdermal Drug Delivery System Market, For Hormonal Applications by Application – Revenue and Forecast to 2030 (US$ Million)
Table 13. Japan: Asia Pacific Transdermal Drug Delivery System Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 14. India: Asia Pacific Transdermal Drug Delivery System Market, by Type – Revenue and Forecast to 2030 (US$ Million)
Table 15. India: Asia Pacific Transdermal Drug Delivery System Market, For Transdermal Patches by Type – Revenue and Forecast to 2030 (US$ Million)
Table 16. India: Asia Pacific Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 17. India: Asia Pacific Transdermal Drug Delivery System Market, For Pain Management by Application – Revenue and Forecast to 2030 (US$ Million)
Table 18. India: Asia Pacific Transdermal Drug Delivery System Market, For Hormonal Applications by Application – Revenue and Forecast to 2030 (US$ Million)
Table 19. India: Asia Pacific Transdermal Drug Delivery System Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 20. Australia: Asia Pacific Transdermal Drug Delivery System Market, by Type – Revenue and Forecast to 2030 (US$ Million)
Table 21. Australia: Asia Pacific Transdermal Drug Delivery System Market, For Transdermal Patches by Type – Revenue and Forecast to 2030 (US$ Million)
Table 22. Australia: Asia Pacific Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 23. Australia: Asia Pacific Transdermal Drug Delivery System Market, For Pain Management by Application – Revenue and Forecast to 2030 (US$ Million)
Table 24. Australia: Asia Pacific Transdermal Drug Delivery System Market, For Hormonal Applications by Application – Revenue and Forecast to 2030 (US$ Million)
Table 25. Australia: Asia Pacific Transdermal Drug Delivery System Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 26. South Korea: Asia Pacific Transdermal Drug Delivery System Market, by Type – Revenue and Forecast to 2030 (US$ Million)
Table 27. South Korea: Asia Pacific Transdermal Drug Delivery System Market, For Transdermal Patches by Type – Revenue and Forecast to 2030 (US$ Million)
Table 28. South Korea: Asia Pacific Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 29. South Korea: Asia Pacific Transdermal Drug Delivery System Market, For Pain Management by Application – Revenue and Forecast to 2030 (US$ Million)
Table 30. South Korea: Asia Pacific Transdermal Drug Delivery System Market, For Hormonal Applications by Application – Revenue and Forecast to 2030 (US$ Million)
Table 31. South Korea: Asia Pacific Transdermal Drug Delivery System Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 32. Rest of Asia Pacific: Asia Pacific Transdermal Drug Delivery System Market, by Type – Revenue and Forecast to 2030 (US$ Million)
Table 33. Rest of Asia Pacific: Asia Pacific Transdermal Drug Delivery System Market, For Transdermal Patches by Type – Revenue and Forecast to 2030 (US$ Million)
Table 34. Rest of Asia Pacific: Asia Pacific Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 35. Rest of Asia Pacific: Asia Pacific Transdermal Drug Delivery System Market, For Pain Management by Application – Revenue and Forecast to 2030 (US$ Million)
Table 36. Rest of Asia Pacific: Asia Pacific Transdermal Drug Delivery System Market, For Hormonal Applications by Application – Revenue and Forecast to 2030 (US$ Million)
Table 37. Rest of Asia Pacific: Asia Pacific Transdermal Drug Delivery System Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 38. Recent Inorganic Growth Strategies in the Transdermal Drug Delivery System Market
Table 39. Recent Organic Growth Strategies in the Transdermal Drug Delivery System Market
Table 40. Glossary of Terms, Asia Pacific Transdermal Drug Delivery System Market
Table 2. China: Asia Pacific Transdermal Drug Delivery System Market, by Type – Revenue and Forecast to 2030 (US$ Million)
Table 3. China: Asia Pacific Transdermal Drug Delivery System Market, For Transdermal Patches by Type – Revenue and Forecast to 2030 (US$ Million)
Table 4. China: Asia Pacific Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 5. China: Asia Pacific Transdermal Drug Delivery System Market, For Pain Management by Application – Revenue and Forecast to 2030 (US$ Million)
Table 6. China: Asia Pacific Transdermal Drug Delivery System Market, For Hormonal Applications by Application – Revenue and Forecast to 2030 (US$ Million)
Table 7. China: Asia Pacific Transdermal Drug Delivery System Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 8. Japan: Asia Pacific Transdermal Drug Delivery System Market, by Type – Revenue and Forecast to 2030 (US$ Million)
Table 9. Japan: Asia Pacific Transdermal Drug Delivery System Market, For Transdermal Patches by Type – Revenue and Forecast to 2030 (US$ Million)
Table 10. Japan: Asia Pacific Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 11. Japan: Asia Pacific Transdermal Drug Delivery System Market, For Pain Management by Application – Revenue and Forecast to 2030 (US$ Million)
Table 12. Japan: Asia Pacific Transdermal Drug Delivery System Market, For Hormonal Applications by Application – Revenue and Forecast to 2030 (US$ Million)
Table 13. Japan: Asia Pacific Transdermal Drug Delivery System Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 14. India: Asia Pacific Transdermal Drug Delivery System Market, by Type – Revenue and Forecast to 2030 (US$ Million)
Table 15. India: Asia Pacific Transdermal Drug Delivery System Market, For Transdermal Patches by Type – Revenue and Forecast to 2030 (US$ Million)
Table 16. India: Asia Pacific Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 17. India: Asia Pacific Transdermal Drug Delivery System Market, For Pain Management by Application – Revenue and Forecast to 2030 (US$ Million)
Table 18. India: Asia Pacific Transdermal Drug Delivery System Market, For Hormonal Applications by Application – Revenue and Forecast to 2030 (US$ Million)
Table 19. India: Asia Pacific Transdermal Drug Delivery System Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 20. Australia: Asia Pacific Transdermal Drug Delivery System Market, by Type – Revenue and Forecast to 2030 (US$ Million)
Table 21. Australia: Asia Pacific Transdermal Drug Delivery System Market, For Transdermal Patches by Type – Revenue and Forecast to 2030 (US$ Million)
Table 22. Australia: Asia Pacific Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 23. Australia: Asia Pacific Transdermal Drug Delivery System Market, For Pain Management by Application – Revenue and Forecast to 2030 (US$ Million)
Table 24. Australia: Asia Pacific Transdermal Drug Delivery System Market, For Hormonal Applications by Application – Revenue and Forecast to 2030 (US$ Million)
Table 25. Australia: Asia Pacific Transdermal Drug Delivery System Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 26. South Korea: Asia Pacific Transdermal Drug Delivery System Market, by Type – Revenue and Forecast to 2030 (US$ Million)
Table 27. South Korea: Asia Pacific Transdermal Drug Delivery System Market, For Transdermal Patches by Type – Revenue and Forecast to 2030 (US$ Million)
Table 28. South Korea: Asia Pacific Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 29. South Korea: Asia Pacific Transdermal Drug Delivery System Market, For Pain Management by Application – Revenue and Forecast to 2030 (US$ Million)
Table 30. South Korea: Asia Pacific Transdermal Drug Delivery System Market, For Hormonal Applications by Application – Revenue and Forecast to 2030 (US$ Million)
Table 31. South Korea: Asia Pacific Transdermal Drug Delivery System Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 32. Rest of Asia Pacific: Asia Pacific Transdermal Drug Delivery System Market, by Type – Revenue and Forecast to 2030 (US$ Million)
Table 33. Rest of Asia Pacific: Asia Pacific Transdermal Drug Delivery System Market, For Transdermal Patches by Type – Revenue and Forecast to 2030 (US$ Million)
Table 34. Rest of Asia Pacific: Asia Pacific Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 35. Rest of Asia Pacific: Asia Pacific Transdermal Drug Delivery System Market, For Pain Management by Application – Revenue and Forecast to 2030 (US$ Million)
Table 36. Rest of Asia Pacific: Asia Pacific Transdermal Drug Delivery System Market, For Hormonal Applications by Application – Revenue and Forecast to 2030 (US$ Million)
Table 37. Rest of Asia Pacific: Asia Pacific Transdermal Drug Delivery System Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 38. Recent Inorganic Growth Strategies in the Transdermal Drug Delivery System Market
Table 39. Recent Organic Growth Strategies in the Transdermal Drug Delivery System Market
Table 40. Glossary of Terms, Asia Pacific Transdermal Drug Delivery System Market
LIST OF FIGURES
Figure 1. Asia Pacific Transdermal Drug Delivery System Market Segmentation, By Country
Figure 2. Asia Pacific Transdermal Drug Delivery System Market: Key Industry Dynamics
Figure 3. Asia Pacific Transdermal Drug Delivery System Market: Impact Analysis of Drivers and Restraints
Figure 4. Asia Pacific Transdermal Drug Delivery System Market Revenue (US$ Mn), 2020 – 2030
Figure 5. Asia Pacific Transdermal Drug Delivery System Market Revenue Share, by Type 2022 & 2030 (%)
Figure 6. Transdermal Patches: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7. Drug-in-Adhesive Patches: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Matrix Patches: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Reservoir Membrane Patches: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Vapor Patches: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Transdermal Gels: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Transdermal Sprays: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Others: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Asia Pacific Transdermal Drug Delivery System Market Revenue Share, by Application 2022 & 2030 (%)
Figure 15. Cardiovascular Diseases: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Central Nervous System Disorders: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Pain Management: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Opioid: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Non-Opioid: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Hormonal Applications: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Transdermal Estrogen & Progesterone Therapy: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Testosterone Replacement: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. Other Application: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 24. Asia Pacific Transdermal Drug Delivery System Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
Figure 25. Hospital Pharmacies: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 26. Retail Pharmacies: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 27. Online Pharmacies: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 28. Others: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 29. Asia Pacific Transdermal Drug Delivery System Market, by Key Country – Revenue (2022) (US$ Million)
Figure 30. Asia Pacific Transdermal Drug Delivery System Market, by Country, 2022 & 2030 (%)
Figure 31. China: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 32. Japan: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 33. India: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 34. Australia: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 35. South Korea: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 36. Rest of Asia Pacific: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 37. Growth Strategies in the Transdermal Drug Delivery System Market
Figure 2. Asia Pacific Transdermal Drug Delivery System Market: Key Industry Dynamics
Figure 3. Asia Pacific Transdermal Drug Delivery System Market: Impact Analysis of Drivers and Restraints
Figure 4. Asia Pacific Transdermal Drug Delivery System Market Revenue (US$ Mn), 2020 – 2030
Figure 5. Asia Pacific Transdermal Drug Delivery System Market Revenue Share, by Type 2022 & 2030 (%)
Figure 6. Transdermal Patches: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7. Drug-in-Adhesive Patches: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Matrix Patches: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Reservoir Membrane Patches: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Vapor Patches: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Transdermal Gels: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Transdermal Sprays: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Others: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Asia Pacific Transdermal Drug Delivery System Market Revenue Share, by Application 2022 & 2030 (%)
Figure 15. Cardiovascular Diseases: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Central Nervous System Disorders: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Pain Management: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Opioid: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Non-Opioid: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Hormonal Applications: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Transdermal Estrogen & Progesterone Therapy: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Testosterone Replacement: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. Other Application: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 24. Asia Pacific Transdermal Drug Delivery System Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
Figure 25. Hospital Pharmacies: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 26. Retail Pharmacies: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 27. Online Pharmacies: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 28. Others: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 29. Asia Pacific Transdermal Drug Delivery System Market, by Key Country – Revenue (2022) (US$ Million)
Figure 30. Asia Pacific Transdermal Drug Delivery System Market, by Country, 2022 & 2030 (%)
Figure 31. China: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 32. Japan: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 33. India: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 34. Australia: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 35. South Korea: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 36. Rest of Asia Pacific: Asia Pacific Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 37. Growth Strategies in the Transdermal Drug Delivery System Market
1. Boehringer Ingelheim International GmbH
2. GSK Plc
3. Hisamitsu Pharmaceutical Co Inc
4. Johnson & Johnson
5. Luye Pharma Group Ltd
6. Novartis AG
7. Viatris Inc
Be the first to review “Asia Pacific Transdermal Drug Delivery System Market Forecast to 2030”
You must be logged in to post a review.
Reviews
There are no reviews yet.